CCRN

Cross Country Healthcare, Inc. [CCRN] Stock Forecast

Q: What is Cross Country Healthcare, Inc. stock symbol ?

Cross Country Healthcare, Inc. is a US stock, located in Boca raton of Fl and trading under the symbol CCRN

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

CCRN Stock Summary

The Moving Average Convergence Divergence (MACD) for CCRN recently turned positive (within last 10 days).

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 quarters (Quarter statements)

CCRN has less than 1 year of cash runway

Top 10 Correlated Stocks

CCRN

In the News

CCRN Financial details

Company Rating

Buy

Market Cap

609.78M

Income

72.63M

Revenue

2.02B

Book val./share

13.73

Cash/share

0.5

Dividend

Dividend %

Employees

13.13K

Optionable

Shortable

Yes

Earnings

01 May 2024

P/E

7.82

Forward P/E

PEG

-1.31

P/S

0.36

P/B

1.71

P/C

34.8

P/FCF

3.49

Quick Ratio

2.38

Current Ratio

2.43

Debt / Equity

0.01

LT Debt / Equity

0.01

EPS (TTM)

2.05

EPS next Y

EPS next Q

EPS this Y

-59.33%

EPS next Y

EPS next 5Y

EPS last 5Y

NAN%

Revenue last 5Y

19.69%

Revenue Q/Q

-6.39%

EPS Q/Q

-29.73%

SMA20

-5.56%

SMA50

-19.05%

SMA100

-19.05%

Inst Own

83.74%

Inst Trans

0.82%

ROA

14%

ROE

22%

ROC

0.29%

Gross Margin

22%

Oper. Margin

Profit Margin

Payout

Shs Outstand

Shs Float

Target Price

52W Range

15.65-28.75

52W High

-37.86%

52W Low

+16%

RSI

Rel Volume

0.11

Avg Volume

508.69K

Volume

54.25K

Perf Week

-0.57%

Perf Month

-8.08%

Perf Quarter

-24.41%

Perf Half Y

-23.62%

Beta

0.753

Volatility

0.27%, 0.61%

Prev Close

1.58%

Price

17.4

Change

3.02%

CCRN Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	22.96	23.18	45.7	75.83	57.45
Net income per share	-1.56	-0.34	3.6	5.09	2.07
Operating cash flow per share	0.15	0.75	-2.33	3.62	7.19
Free cash flow per share	0.07	0.63	-2.53	3.38	6.79
Cash per share	0.03	0.04	0.03	0.1	0.49
Book value per share	4.54	4.28	8.11	12.35	13.46
Tangible book value per share	0.32	0.64	3.54	6.73	8.06
Share holders equity per share	4.54	4.28	8.11	12.35	13.46
Interest debt per share	2.8	2.11	5.52	4.65	0.38
Market cap	416.17M	320.1M	1.02B	983.41M	795.98M
Enterprise value	510.06M	391.65M	1.21B	1.14B	784.15M
P/E ratio	-7.44	-26.36	7.72	5.22	10.96
Price to sales ratio	0.51	0.38	0.61	0.35	0.39
POCF ratio	75.09	11.77	-11.9	7.34	3.15
PFCF ratio	159.94	14.17	-10.98	7.85	3.33
P/B Ratio	2.56	2.07	3.42	2.15	1.68
PTB ratio	2.56	2.07	3.42	2.15	1.68
EV to sales	0.62	0.47	0.72	0.41	0.39
Enterprise value over EBITDA	23.06	13.67	7.56	3.73	5.79
EV to operating cash flow	92.04	14.4	-14.17	8.49	3.1
EV to free cash flow	196.03	17.34	-13.07	9.08	3.28
Earnings yield	-0.13	-0.04	0.13	0.19	0.09
Free cash flow yield	0.01	0.07	-0.09	0.13	0.3
Debt to equity	0.58	0.47	0.66	0.35	0.01
Debt to assets	0.25	0.2	0.27	0.17	0.01
Net debt to EBITDA	4.24	2.5	1.21	0.51	-0.09
Current ratio	2.15	1.96	2.54	2.49	2.79
Interest coverage	1.52	5.53	20.29	18.98	14.47
Income quality	-0.1	-2.24	-0.65	0.71	3.48
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.21	0.2	0.12	0.11	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.4	0.37	0.23	0.22	0.28
Capex to operating cash flow	-0.53	-0.17	0.08	-0.07	-0.06
Capex to revenue	0	-0.01	0	0	-0.01
Capex to depreciation	-0.21	-0.36	-0.73	-0.7	-0.76
Stock based compensation to revenue	0	0.01	0	0	0
Graham number	12.63	5.69	25.62	37.62	25.02
ROIC	0.07	0.06	0.27	0.32	0.17
Return on tangible assets	-0.24	-0.05	0.23	0.25	0.15
Graham Net	-2.34	-1.85	-1.53	0.36	2.91
Working capital	97.89M	89.69M	308.5M	404.03M	266.57M
Tangible asset value	11.58M	23.25M	129.79M	249.23M	283.5M
Net current asset value	-35.52M	-18.95M	72.99M	185.05M	209.23M
Invested capital	0.58	0.47	0.66	0.35	0.01
Average receivables	172.43M	174.62M	336.83M	579.46M	524.15M
Average payables	44.74M	47.8M	79.82M	147.63M	127.45M
Average inventory	6.15M	5.78M	6.55M	9.36M	5.53M
Days sales outstanding	77.48	76.24	108.62	85.83	70.18
Days payables outstanding	27	28.73	30.78	31.08	15.95
Days of inventory on hand	3.6	3.14	2.14	1.85	0
Receivables turnover	4.71	4.79	3.36	4.25	5.2
Payables turnover	13.52	12.7	11.86	11.75	22.88
Inventory turnover	101.4	116.17	170.2	196.88	0
ROE	-0.34	-0.08	0.44	0.41	0.15
Capex per share	-0.08	-0.13	-0.2	-0.24	-0.4

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	17.23	17.36	15.3	12.65	12.01
Net income per share	1.06	0.82	0.6	0.37	0.26
Operating cash flow per share	0.12	1.31	3.37	2.01	0.48
Free cash flow per share	0.06	1.2	3.26	1.91	0.39
Cash per share	0.1	0.01	0.02	0.41	0.5
Book value per share	12.54	12.6	13.31	13.44	13.73
Tangible book value per share	6.84	6.9	7.73	7.92	8.22
Share holders equity per share	12.54	12.6	13.31	13.44	13.73
Interest debt per share	4.42	4.17	1.15	0.19	0.17
Market cap	968.61M	800.48M	992.66M	866.51M	780.65M
Enterprise value	1.12B	946.07M	1.03B	858.03M	768.82M
P/E ratio	6.24	6.8	11.63	16.91	21.59
Price to sales ratio	1.54	1.29	1.84	1.96	1.89
POCF ratio	224.22	17.08	8.32	12.32	47.47
PFCF ratio	421.68	18.54	8.61	12.96	57.53
P/B Ratio	2.12	1.77	2.11	1.84	1.65
PTB ratio	2.12	1.77	2.11	1.84	1.65
EV to sales	1.79	1.52	1.9	1.94	1.86
Enterprise value over EBITDA	19.36	17.15	27.17	31.09	42.65
EV to operating cash flow	259.9	20.19	8.63	12.2	46.75
EV to free cash flow	488.79	21.91	8.93	12.83	56.66
Earnings yield	0.04	0.04	0.02	0.01	0.01
Free cash flow yield	0	0.05	0.12	0.08	0.02
Debt to equity	0.35	0.32	0.08	0.01	0.01
Debt to assets	0.17	0.16	0.05	0.01	0.01
Net debt to EBITDA	2.66	2.64	0.97	-0.31	-0.66
Current ratio	2.49	2.45	2.34	2.43	2.79
Interest coverage	14.64	11.87	11.17	30.35	22.91
Income quality	0.11	1.59	5.59	524.71	1.82
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.1	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.22	0.22	0.26	0.27	0.28
Capex to operating cash flow	-0.47	-0.08	-0.03	-0.05	-0.17
Capex to revenue	0	-0.01	-0.01	-0.01	-0.01
Capex to depreciation	-0.64	-0.75	-0.9	-0.75	-0.64
Stock based compensation to revenue	0	0	0	0	0
Graham number	17.33	15.25	13.44	10.53	9
ROIC	0.07	0.05	0.05	0.03	0.02
Return on tangible assets	0.05	0.04	0.04	0.02	0.02
Graham Net	0.37	0.4	2.15	2.75	2.97
Working capital	404.03M	383.7M	289.61M	261.65M	266.57M
Tangible asset value	249.23M	247.32M	273.16M	276.98M	283.5M
Net current asset value	185.05M	180M	204.85M	207.15M	209.23M
Invested capital	0.35	0.32	0.08	0.01	0.01
Average receivables	638.53M	648.04M	566.48M	460.13M	405.88M
Average payables	188.77M	181.19M	158.22M	127.18M	92.09M
Average inventory	7.51M	11M	8.85M	5.77M	2.39M
Days sales outstanding	94.55	91.94	82.7	86.16	84.42
Days payables outstanding	34.12	32.94	30.08	29.95	19.04
Days of inventory on hand	2.04	2.04	1.46	1.25	0
Receivables turnover	0.95	0.98	1.09	1.04	1.07
Payables turnover	2.64	2.73	2.99	3	4.73
Inventory turnover	44.21	44.19	61.83	72.18	0
ROE	0.08	0.07	0.05	0.03	0.02
Capex per share	-0.06	-0.1	-0.11	-0.1	-0.08

CCRN Frequently Asked Questions

What is Cross Country Healthcare, Inc. stock symbol ?

Cross Country Healthcare, Inc. is a US stock , located in Boca raton of Fl and trading under the symbol CCRN

What is Cross Country Healthcare, Inc. stock quote today ?

Cross Country Healthcare, Inc. stock price is $17.4 today.

Is Cross Country Healthcare, Inc. stock public?

Yes, Cross Country Healthcare, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 508.69K
Market Capitalization 609.78M
Employee 13.13K
CEO Mr. John A. Martins
Headquarters Boca Raton,FL,US
IPO Date 2001-10-25
Website https://www.crosscountryhealthcare.com

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.